JXG: Shunt, Central Nervous System And Components
What it covers
A central nervous system fluid shunt is a device or combination of devices used to divert fluid from the brain or other part of the central nervous system to an internal delivery site or an external receptacle for the purpose of relieving elevated intracranial pressure or fluid volume (e.g., due to hydrocephalus). Components of a central nervous system shunt include catheters, valved catheters, valves, connectors, and other accessory components intended to facilitate use of the shunt or evaluation of a patient with a shunt.
The identification in 21 CFR 882.5550, central nervous system fluid shunt and components. FDA gives JXG no definition of its own, so the regulation’s describes it.
FDA flags JXG devices as implants.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K260044 | Ventricular Catheters, Thomale Catheter | Aesculap, Inc. | Oct 2, 2026 | Traditional |
| K261004 | Codman® Distal Peritoneal Catheter, Barium Open End (82-1682); Codman® HOLTER® Peritoneal Catheter (SALMON Design) (82-1684) | Integra Lifesciences Production Corporation | Jun 23, 2026 | Traditional |
| K251598 | Intellidrop | Brainspace, Inc. | Dec 10, 2025 | Traditional |
| K250636 | Sophy Mini Monopressure Valve (SM1) | Sophysa | Nov 28, 2025 | Traditional |
| K252514 | EVAC-MRI | Phasor Health, LLC | Nov 5, 2025 | Traditional |
| K243531 | Codman Libertís Shunt Catheter with Bactiseal and Endexo Technology | Integra Lifesciences Production Corporation | Aug 8, 2025 | Traditional |
| K243552 | Codman Libertís 1.5 mm EVD Catheter with Bactiseal® and Endexo® Technology with Luer Connection (821761); Codman Libertís 1.9 mm EVD Catheter with Bactiseal® and Endexo® Technology with Luer Connection (821762) | Integra Lifesciences Production Corporation | Aug 6, 2025 | Traditional |
| K242974 | External CSF Drainage Ventricular Catheters, External CSF Drainage Lumbar Catheters | Sophysa | Jun 20, 2025 | Traditional |
| K243205 | EVAC | Phasor Health, LLC | Jun 3, 2025 | Traditional |
| K243676 | Duet External Drainage and Monitoring System (EDMS) | Medtronic Neurosurgery | Mar 10, 2025 | Traditional |
Clearances by year
67 JXG 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 2 | 179 |
| 2025 | 8 | 255 |
| 2024 | 3 | 90 |
| 2023 | 5 | 134 |
| 2022 | 4 | 101 |
| 2021 | 1 | 27 |
| 2020 | 2 | 31 |
| 2019 | 4 | 101 |
| 2018 | 6 | 102 |
| 2017 | 7 | 90 |
| 2016 | 6 | 143 |
| 2015 | 6 | 276 |
| 2013 | 3 | 108 |
| 2012 | 3 | 78 |
| 2011 | 7 | 136 |
Who submits
24 applicants cleared a JXG device since 2011. 90% of the clearances went to applicants in United States, then France (4%), Switzerland (3%) and China (1%). By type: Traditional 82% and Special 18%.
| Applicant | Clearances since 2011 |
|---|---|
| Aesculap, Inc. | 9 |
| Codman & Shurtleff, Inc. | 7 |
| Integra Lifesciences Production Corporation | 7 |
| Integra LifeSciences Corporation | 6 |
| Medtronic Neurosurgery | 6 |
| Aqueduct Critical Care, Inc. | 4 |
| Medos International SARL | 4 |
| Sophysa | 3 |
How FDA classifies it
Class II (performance standards).
From 21 CFR 882.5550.
Standards
21 CFR 882.5550 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent JXG clearances declared.
Ask about JXG
Questions about JXG
What is FDA product code JXG?
Product code JXG, “Shunt, Central Nervous System And Components” in FDA's classification database, is a Class II device type under 21 CFR 882.5550 (central nervous system fluid shunt and components), reviewed by FDA's Neurology panel. FDA's 510(k) database lists 260 clearances under JXG, 67 of them since 2011.
How many 510(k) clearances are there under JXG?
FDA’s 510(k) database listed 260 clearances under JXG as of Oct 29, 2026, 67 of them decided since 2011; the most recent decision was Oct 2, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a JXG 510(k)?
For the 11 JXG clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 245 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most JXG clearances?
Since 2011: Aesculap, Inc. (9), Codman & Shurtleff, Inc. (7), Integra Lifesciences Production Corporation (7), Integra LifeSciences Corporation (6) and Medtronic Neurosurgery (6). 24 applicants have cleared a JXG device in that time.